Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Warfarin, sold under the brand name Coumadin among others, is used as an anticoagulant medication. It is commonly used to prevent deep vein thrombosis and pulmonary embolism, and to protect against stroke in people who have atrial fibrillation, valvular heart disease, or artificial heart valves. Warfarin may sometimes be prescribed following a ST-segment…
The analysis highlights History, Applications and Art as prominent areas in the source structure around Warfarin.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Warfarin shows recurring relationship patterns in the source. For example, Warfarin → Aldocumar, Anasmol, Anticoag, Befarin, Cavamed, Cicoxil, Circuvit, Co-Rax, Cofarin, Con, Coumadin, Coumadine, Cov-R-Tox, Cumar, Dethmor, Farin, Foley, France, Haemofarin, Jantoven Another extracted example is Warfarin → Biotechnology Information, Bookshelf ID, CYP Genotype, Dean, Dean LC, In Pratt VM, Kattman BL, McLeod HL, Medical Genetics Summaries, National Center, NBK84174, NCBI, PMID, Rubinstein WS, Scott SA, VKORC1, Warfarin Therapy. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
vitamin inr bleeding also used may use risk effect anticoagulant many k1 blood clotting increased factors thrombosis effects several people
TTTA extracted 273 structured relationships around Warfarin. Examples in this analysis include Warfarin → 3D model (JSmol) → Interactive image and Warfarin → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Warfarin | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Warfarin | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Warfarin | ATC code | B01AA03 (WHO) QB01AA03 (WHO) | 1.00 | infobox |
| Warfarin | Bioavailability | 79–100% (by mouth) | 1.00 | infobox |
| Warfarin | CAS Number | 81-81-2 Y | 1.00 | infobox |
| Warfarin | CAS Number | as salt: 129-06-6 | 1.00 | infobox |
| Warfarin | ChEBI | CHEBI:10033 Y | 1.00 | infobox |
| Warfarin | ChEBI | as salt: CHEBI:10034 | 1.00 | infobox |
| Warfarin | ChEMBL | ChEMBL1464 N | 1.00 | infobox |
| Warfarin | ChEMBL | as salt: ChEMBL1200879 | 1.00 | infobox |
| Warfarin | ChemSpider | 10442445 Y | 1.00 | infobox |
| Warfarin | ChemSpider | as salt: 17333193 | 1.00 | infobox |
| Warfarin | DrugBank | DB00682 N | 1.00 | infobox |
| Warfarin | DrugBank | as salt: DBSALT000278 | 1.00 | infobox |
| Warfarin | ECHA InfoCard | 100.001.253 | 1.00 | infobox |
| Warfarin | Elimination half-life | 7 days (active half-life is 20-60 hours) | 1.00 | infobox |
| Warfarin | Excretion | Kidney (92%) | 1.00 | infobox |
| Warfarin | Formula | C19H16O4 | 1.00 | infobox |
| Warfarin | IUPHAR/BPS | 6853 | 1.00 | infobox |
| Warfarin | KEGG | D08682 Y | 1.00 | infobox |
| Warfarin | KEGG | as salt: D00564 | 1.00 | infobox |
| Warfarin | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Warfarin | Legal status | CA: ℞-only | 1.00 | infobox |
| Warfarin | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Warfarin | Legal status | US: ℞-only | 1.00 | infobox |
| Warfarin | License data | US DailyMed: Warfarin | 1.00 | infobox |
| Warfarin | MedlinePlus | a682277 | 1.00 | infobox |
| Warfarin | Metabolism | Liver: CYP2C9, 2C19, 2C8, 2C18, 1A2 and 3A4 | 1.00 | infobox |
| Warfarin | Molar mass | 308.333 g·mol−1 | 1.00 | infobox |
| Warfarin | PDB ligand | RWF (PDBe, RCSB PDB) | 1.00 | infobox |
The concept neighborhoods around Warfarin bring nearby vocabulary together. In this analysis, examples include Use, Used and Effect. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Warfarin, one of the stronger structural bridges in this analysis connects Warfarin with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Warfarin to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Applications & Art, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Warfarin · EN edition · Analysis: TopicsToTalkAbout